What are the major opportunities in the Diabetic Macular Edema (DME) market? What are the strategies for the Diabetic Macular Edema (DME) market?

For detailed insights on the major opportunities and strategies in the Diabetic Macular Edema (DME) market, Read More

How does the Diabetic Macular Edema (DME) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Diabetic Macular Edema (DME) market growth and SWOT analysis of the Diabetic Macular Edema (DME) industry, Read More

For detailed insights on the mergers and acquisitions in the Diabetic Macular Edema (DME) industry,

What are the key dynamics influencing the Diabetic Macular Edema (DME) market growth? SWOT analysis of the Diabetic Macular Edema (DME) market. Read More

Diabetic Macular Edema (DME) Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Diabetic Macular Edema (DME) Market Report 2026

Name: Diabetic Macular Edema (DME) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention ), By Disease Stage (Early Stage, Moderate Stage, Advanced Stage ), By Patient Demographics (Adults, Elderly, Children), By Route Of Administration (Intravitreal Injection, Topical, Systemic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Diabetic Macular Edema (DME) Market Overview

• Diabetic Macular Edema (DME) market size has reached to $4.88 billion in 2025

• Expected to grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%

• Growth Driver: Rising Diabetes Prevalence And Its Impact On Eye Health

• Market Trend: Innovations In Sustained Ocular Therapy Transform Vision Management

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Diabetic Macular Edema (DME) Market?

Diabetic macular edema (DME) is a complication of diabetes that occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. This swelling is caused by damaged blood vessels leaking fluid and proteins into the retinal tissue, leading to vision impairment or blindness if left untreated. DME is a common cause of vision loss in diabetic patients and is associated with diabetic retinopathy.

The main treatments of diabetic macular edema (DME) are anti-VEGF therapy, corticosteroids, laser therapy, and surgical intervention. Anti-VEGF therapy works by inhibiting vascular endothelial growth factor (VEGF), a protein responsible for abnormal blood vessel growth and retinal leakage, which contribute to diabetic macular edema (DME). The disease progresses through stages such as early stage, moderate stage, and advanced stage. Patient demographics are categorized by age group, including adults, elderly, and children. Routes of administration consist of intravitreal injection, topical, and systemic methods, and it is distributed by hospital pharmacies, retail pharmacies, and online pharmacies.

Diabetic Macular Edema (DME) Market Global Report 2026 Market Report bar graph

What Is The Diabetic Macular Edema (DME) Market Size and Share 2026?

The diabetic macular edema (dme) market size has grown steadily in recent years. It will grow from $4.88 billion in 2025 to $5.09 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rising prevalence of diabetic eye disease, limited early detection practices, increasing vision impairment cases, reliance on hospital-based ophthalmology care, growth in diabetes duration.

What Is The Diabetic Macular Edema (DME) Market Growth Forecast?

The diabetic macular edema (dme) market size is expected to see steady growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to advancements in biologic therapies, expansion of ai-driven eye screening, growth of specialty eye clinics, increasing awareness of diabetic eye complications, aging diabetic population. Major trends in the forecast period include increasing adoption of anti-vegf therapies, rising use of advanced retinal imaging technologies, expansion of early diagnosis and monitoring programs, growing focus on vision preservation treatments, integration of AI-based ophthalmic screening.

Book your 30 minutes free consultation with our research experts

Global Diabetic Macular Edema (DME) Market Segmentation

1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention

2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage

3) By Patient Demographics: Adults, Elderly, Children

4) By Route Of Administration: Intravitreal Injection, Topical, Systemic

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies

2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids

3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation

4) By Surgical Intervention: Vitrectomy, Membrane Peeling

What Is The Driver Of The Diabetic Macular Edema (DME) Market?

The increase in prevalence of diabetes is expected to drive the growth of the diabetic macular edema (DME) market going forward. The increasing prevalence of diabetes is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition. Diabetes causes diabetic macular edema by damaging retinal blood vessels, leading to leakage of fluid into the macula and resulting in swelling. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increase in prevalence of diabetes is driving the growth of the diabetic macular edema (DME) industry.

Key Players In The Global Diabetic Macular Edema (DME) Market

Major companies operating in the diabetic macular edema (dme) market are Roche Holding AG, Bayer AG, Novartis AG, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Optos plc, Allergan plc, Chengdu Kanghong Pharmaceutical Group, Kodiak Sciences, Opthea Limited, Oxurion NV, Aerie Pharmaceuticals Inc, Coherus BioSciences, KalVista Pharmaceuticals Inc, Araim Pharmaceuticals Inc, Acucela Inc, Antisense Therapeutics Limited, BCN Peptides SA, Ampio Pharmaceuticals Inc, Oculis SA, ThromboGenics NV, EyePoint Pharmaceuticals Inc.

Global Diabetic Macular Edema (DME) Market Trends and Insights

Major companies operating in the diabetic macular edema (DME) market are focusing on incorporating sustained-delivery implant technology such as refillable ocular implants to enhance treatment durability, patient compliance, and vision-maintenance efficiency. Refillable ocular implants are devices surgically placed in the eye that continuously release medication over extended periods, enabling capabilities such as less frequent dosing, sustained therapeutic exposure, and reduced treatment burden. For instance, in February 2025, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and pharmaceutical company, received approval for Susvimo (ranibizumab 100 mg/mL delivered via the port delivery platform), a refillable ocular implant designed to treat DME, featuring continuous delivery of ranibizumab, refill intervals as infrequent as twice per year, and non-inferior vision outcomes compared with monthly intravitreal injections. Susvimo improves patient adherence, reduces injection burden, and supports sustained vision preservation.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Diabetic Macular Edema (DME) Market?

In July 2024, Merck & Co Inc, a US-based pharmaceutical company, acquired Eyebiotech Limited for $1.3 billion. This acquisition allows Merck & Co. to strengthen its portfolio, boost research capabilities, and secure access to Restoret (EYE-103), a promising treatment for diabetic macular edema (DME) and treatment-naive neovascular age-related macular degeneration (AMD), positioning the company to address significant unmet needs in ophthalmology. Eyebiotech Limited (EyeBio) is a UK-based biotechnology company specializing in ophthalmology.

Regional Outlook

North America was the largest region in the diabetic macular edema (DME) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetic Macular Edema (DME) Market?

The diabetic macular edema (DME) market consists of revenues earned by entities by providing services such as retinal imaging, fluorescein angiography, visual acuity testing, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetic macular edema market includes sales of ranibizumab, aflibercep, fluocinolone acetonide intravitreal implant, and dexamethasone intravitreal implant. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetic Macular Edema (DME) Market Report 2026?

The diabetic macular edema (dme) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic macular edema (dme) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Diabetic Macular Edema (DME) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.09 billion
Revenue Forecast In 2035	$6 billion
Growth Rate	CAGR of 4.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Disease Stage, Patient Demographics, Route Of Administration, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche Holding AG, Bayer AG, Novartis AG, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Optos plc, Allergan plc, Chengdu Kanghong Pharmaceutical Group, Kodiak Sciences, Opthea Limited, Oxurion NV, Aerie Pharmaceuticals Inc, Coherus BioSciences, KalVista Pharmaceuticals Inc, Araim Pharmaceuticals Inc, Acucela Inc, Antisense Therapeutics Limited, BCN Peptides SA, Ampio Pharmaceuticals Inc, Oculis SA, ThromboGenics NV, EyePoint Pharmaceuticals Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Diabetic Macular Edema (DME) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Diabetic Macular Edema (DME) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Diabetic Macular Edema (DME) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Diabetic Macular Edema (DME) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Anti-Vegf Therapies

4.2.2 Rising Use Of Advanced Retinal Imaging Technologies

4.2.3 Expansion Of Early Diagnosis And Monitoring Programs

4.2.4 Growing Focus On Vision Preservation Treatments

4.2.5 Integration Of Ai-Based Ophthalmic Screening

5. Diabetic Macular Edema (DME) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Specialty Eye Care Centers

5.4 Ambulatory Surgical Centers

5.5 Diagnostic Imaging Centers

6. Diabetic Macular Edema (DME) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Diabetic Macular Edema (DME) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Diabetic Macular Edema (DME) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Diabetic Macular Edema (DME) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Diabetic Macular Edema (DME) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Diabetic Macular Edema (DME) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Diabetic Macular Edema (DME) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Diabetic Macular Edema (DME) Market Segmentation

9.1. Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention

9.2. Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Stage, Moderate Stage, Advanced Stage

9.3. Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adults, Elderly, Children

9.4. Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravitreal Injection, Topical, Systemic

9.5. Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.6. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Recombinant Protein-Based Therapies

9.7. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids

9.8. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Focal Laser Photocoagulation, Panretinal Photocoagulation

9.9. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitrectomy, Membrane Peeling

10. Diabetic Macular Edema (DME) Market Regional And Country Analysis

10.1. Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Diabetic Macular Edema (DME) Market

11.1. Asia-Pacific Diabetic Macular Edema (DME) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Diabetic Macular Edema (DME) Market

12.1. China Diabetic Macular Edema (DME) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Diabetic Macular Edema (DME) Market

13.1. India Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Diabetic Macular Edema (DME) Market

14.1. Japan Diabetic Macular Edema (DME) Market Overview

14.2. Japan Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Diabetic Macular Edema (DME) Market

15.1. Australia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Diabetic Macular Edema (DME) Market

16.1. Indonesia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Diabetic Macular Edema (DME) Market

17.1. South Korea Diabetic Macular Edema (DME) Market Overview

17.2. South Korea Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Diabetic Macular Edema (DME) Market

18.1. Taiwan Diabetic Macular Edema (DME) Market Overview

18.2. Taiwan Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Diabetic Macular Edema (DME) Market

19.1. South East Asia Diabetic Macular Edema (DME) Market Overview

19.2. South East Asia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Diabetic Macular Edema (DME) Market

20.1. Western Europe Diabetic Macular Edema (DME) Market Overview

20.2. Western Europe Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Diabetic Macular Edema (DME) Market

21.1. UK Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Diabetic Macular Edema (DME) Market

22.1. Germany Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Diabetic Macular Edema (DME) Market

23.1. France Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Diabetic Macular Edema (DME) Market

24.1. Italy Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Diabetic Macular Edema (DME) Market

25.1. Spain Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Diabetic Macular Edema (DME) Market

26.1. Eastern Europe Diabetic Macular Edema (DME) Market Overview

26.2. Eastern Europe Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Diabetic Macular Edema (DME) Market

27.1. Russia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Diabetic Macular Edema (DME) Market

28.1. North America Diabetic Macular Edema (DME) Market Overview

28.2. North America Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Diabetic Macular Edema (DME) Market

29.1. USA Diabetic Macular Edema (DME) Market Overview

29.2. USA Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Diabetic Macular Edema (DME) Market

30.1. Canada Diabetic Macular Edema (DME) Market Overview

30.2. Canada Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Diabetic Macular Edema (DME) Market

31.1. South America Diabetic Macular Edema (DME) Market Overview

31.2. South America Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Diabetic Macular Edema (DME) Market

32.1. Brazil Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Diabetic Macular Edema (DME) Market

33.1. Middle East Diabetic Macular Edema (DME) Market Overview

33.2. Middle East Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Diabetic Macular Edema (DME) Market

34.1. Africa Diabetic Macular Edema (DME) Market Overview

34.2. Africa Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Segmentation By Disease Stage, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Diabetic Macular Edema (DME) Market Regulatory and Investment Landscape

36. Diabetic Macular Edema (DME) Market Competitive Landscape And Company Profiles

36.1. Diabetic Macular Edema (DME) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Diabetic Macular Edema (DME) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Diabetic Macular Edema (DME) Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Regeneron Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Carl Zeiss Meditec AG Overview, Products and Services, Strategy and Financial Analysis

37. Diabetic Macular Edema (DME) Market Other Major And Innovative Companies

Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Optos plc, Allergan plc, Chengdu Kanghong Pharmaceutical Group, Kodiak Sciences, Opthea Limited, Oxurion NV, Aerie Pharmaceuticals Inc, Coherus BioSciences, KalVista Pharmaceuticals Inc, Araim Pharmaceuticals Inc, Acucela Inc, Antisense Therapeutics Limited

38. Global Diabetic Macular Edema (DME) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Diabetic Macular Edema (DME) Market

40. Diabetic Macular Edema (DME) Market High Potential Countries, Segments and Strategies

40.1 Diabetic Macular Edema (DME) Market In 2030 - Countries Offering Most New Opportunities

40.2 Diabetic Macular Edema (DME) Market In 2030 - Segments Offering Most New Opportunities

40.3 Diabetic Macular Edema (DME) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Diabetic Macular Edema (DME) Market, Overview Of Key Products - Product Examples

Table 2: Global Diabetic Macular Edema (DME) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Diabetic Macular Edema (DME) Market, Supply Chain Analysis

Table 4: Global Diabetic Macular Edema (DME) Market, Major Raw Material Providers

Table 5: Global Diabetic Macular Edema (DME) Market, Major Resource Providers

Table 6: Global Diabetic Macular Edema (DME) Market, Major Manufacturers (Suppliers)

Table 7: Global Diabetic Macular Edema (DME) Market, Major Distributors And Channel Partners

Table 8: Global Diabetic Macular Edema (DME) Market, Key Technologies & Future Trends

Table 9: Global Diabetic Macular Edema (DME) Market, Major Trends

Table 10: Global Diabetic Macular Edema (DME) Market, Major End Users

Table 11: Global Diabetic Macular Edema (DME) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Diabetic Macular Edema (DME) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Diabetic Macular Edema (DME) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Diabetic Macular Edema (DME) Market - TAM, US$ Billion, 2025

Table 15: Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Diabetic Macular Edema (DME) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Diabetic Macular Edema (DME) Market - Company Scoring Matrix

Table 100: Roche Holding AG Financial Performance

Table 101: Bayer AG Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Regeneron Pharmaceuticals Financial Performance

Table 104: Carl Zeiss Meditec AG Financial Performance

Table 105: Global Diabetic Macular Edema (DME) Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Diabetic Macular Edema (DME) Market, Competitive Dashboard

Table 107: Global Diabetic Macular Edema (DME) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 109: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Disease Stage, 2025 – 2030

Table 110: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

Figure 1: Global Diabetic Macular Edema (DME) Market, Overview Of Key Products - Product Examples

Figure 2: Global Diabetic Macular Edema (DME) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Diabetic Macular Edema (DME) Market, Supply Chain Analysis

Figure 4: Global Diabetic Macular Edema (DME) Market, Major Raw Material Providers

Figure 5: Global Diabetic Macular Edema (DME) Market, Major Resource Providers

Figure 6: Global Diabetic Macular Edema (DME) Market, Major Manufacturers (Suppliers)

Figure 7: Global Diabetic Macular Edema (DME) Market, Major Distributors And Channel Partners

Figure 8: Global Diabetic Macular Edema (DME) Market, Key Technologies & Future Trends

Figure 9: Global Diabetic Macular Edema (DME) Market, Major Trends

Figure 10: Global Diabetic Macular Edema (DME) Market, Major End Users

Figure 11: Global Diabetic Macular Edema (DME) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Diabetic Macular Edema (DME) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Diabetic Macular Edema (DME) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Diabetic Macular Edema (DME) Market - TAM, US$ Billion, 2025

Figure 15: Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Diabetic Macular Edema (DME) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Diabetic Macular Edema (DME) Market - Company Scoring Matrix

Figure 100: Roche Holding AG Financial Performance

Figure 101: Bayer AG Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Regeneron Pharmaceuticals Financial Performance

Figure 104: Carl Zeiss Meditec AG Financial Performance

Figure 105: Global Diabetic Macular Edema (DME) Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Diabetic Macular Edema (DME) Market, Competitive Dashboard

Figure 107: Global Diabetic Macular Edema (DME) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 109: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Disease Stage, 2025 – 2030

Figure 110: Global, Diabetic Macular Edema (DME) Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Diabetic Retinopathy Market Report 2026 - Global Outlook – By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Treatment (Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photoco...

Non-Proliferative Diabetic Retinopathy Market Report 2026 - Global Outlook – By Treatment Type (Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Diseas...

Macular Degeneration Treatment Market Report 2026 - Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration),...

Age-Related Macular Degeneration Market Report 2026 - Global Outlook – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Drugs), By...

Proliferative Diabetic Retinopathy (PDR) Market Report 2026 - Global Outlook – By Treatment Type (Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy), By Mode of Admin...

Diabetic Wounds Market Report 2026 - Global Outlook – By Product Type (Wound Care Dressings, Wound Care Devices, Skin Grafts And Substitutes, Growth Factors, Other Product Types), By Wound Type (Neuropathic Ulcer Wounds,...

Diabetic Neuropathy Market Report 2026 - Global Outlook – By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Drug Class (Analgesics, Anti-Depressants, Anti-Convulsants, O...

Frequently Asked Questions

How big is the Diabetic Macular Edema (DME) Market?

The Diabetic Macular Edema (DME) market was valued at $4.88 billion in 2025, increased to $5.09 billion in 2026, and is projected to reach $6 billion by 2030.

What is the Diabetic Macular Edema (DME) market growth?

The global Diabetic Macular Edema (DME) market is expected to grow at a CAGR of 4.2% from 2026 to 2035 to reach $6 billion by 2035.

Who are the key players in Diabetic Macular Edema (DME) market?

Some Key Players in the Diabetic Macular Edema (DME) market Include, Roche Holding AG, Bayer AG, Novartis AG, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Optos plc, Allergan plc, Chengdu Kanghong Pharmaceutical Group, Kodiak Sciences, Opthea Limited, Oxurion NV, Aerie Pharmaceuticals Inc, Coherus BioSciences, KalVista Pharmaceuticals Inc, Araim Pharmaceuticals Inc, Acucela Inc, Antisense Therapeutics Limited, BCN Peptides SA, Ampio Pharmaceuticals Inc, Oculis SA, ThromboGenics NV, EyePoint Pharmaceuticals Inc. .

What is the anticipated growth trend for the Diabetic Macular Edema (DME) market?

Major trend in this market includes: Innovations In Sustained Ocular Therapy Transform Vision Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Diabetic Macular Edema (DME) market?

North America was the largest region in the diabetic macular edema (DME) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (dme) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.